IMW 2019 | Reducing CAR-T toxicity

Yu-Tzu Tai

Dr. Yu-Tzu Tai, PhD of the Dana-Farber Cancer Institute, Boston, MA describes how CAR-T cells may be used to reduce the toxic effects of therapy and the promise of new antibody-drug conjugates. Recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

Share this video  
Similar topics